Status: Recruiting
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris
Participants needed: 342
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Priovant Therapeutics, Inc.Updated: Apr 16, 2026Locations: 5
Eligibility criteria
Age ≥ 18 years [+3]
History of: Lymphoproliferative disorder; Active malignancy; History of cancer w... [+3]